Related Experiment Video

Updated: Mar 6, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.6K

Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality

Nicola Fazio1, Massimo Milione2

  • 1Unit of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy.

The Oncologist
|March 11, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

10.1K

Related Experiment Videos

Last Updated: Mar 6, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.6K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model
08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

10.1K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

698
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
698

Articles linked to this work by shared authors, journal, and citation graph.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Molecular cancer·2026

Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancer.

Cancer treatment and research communications·2026

Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.

Endocrine-related cancer·2026

Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows.

Cancer treatment reviews·2026

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers.

Journal of neuroendocrinology·2026

A Secret-Shopper Study Evaluating Logistic Barriers to Care Among Young Adults with Acute Lymphoblastic Leukemia.

The oncologist·2026

Central Nervous System Symptom Burden and Clinical Implications for Antiemetic Management with Olanzapine in AC Chemotherapy.

The oncologist·2026

Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

The oncologist·2026

Socioeconomic disparities in sarcoma diagnosis, expert center access, and advocacy group awareness: a multicenter study in Southern Europe.

The oncologist·2026

Real-world characteristics of trastuzumab deruxtecan-related interstitial lung disease in Japanese patients with breast cancer and gastric cancer.

The oncologist·2026

Apatinib monotherapy for pretreated advanced squamous cell carcinoma of the penis: a phase II trial.

The oncologist·2026

Medullary Carcinoma of the Ascending Colon in an Older Woman: A Case Report.

Surgical case reports·2026

Incidentally Diagnosed Very Well-Differentiated Gastric Adenocarcinoma at Intraoperative Frozen Section.

ACG case reports journal·2026

NTRK-positive collision tumor of the gastrointestinal tract: a rare entity case report.

Annals of medicine and surgery (2012)·2026

Extraluminal Colonic Adenocarcinoma Directly Invading the Left Kidney: A Rare Case of Direct Invasion.

Cureus·2026

Müllerian clear cell carcinoma arising from sigmoid endometriosis with pericolic lymph node metastasis in the absence of adnexal disease: a case report.

Frontiers in oncology·2026

Highest mediastinal lymph node metastasis was not an independent prognostic factor in pathological stage N2 non-small cell lung cancer.

Translational lung cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us